Literature DB >> 27994933

Another Reason to Omit Induction Radiotherapy: Save It for Last.

Çağatay Tezel1, Serdar Evman1, Talha Doğruyol1.   

Abstract

Year:  2016        PMID： 27994933      PMCID： PMC5142804          DOI： 10.5152/balkanmedj.2016.160898

Source DB:  PubMed          Journal:  Balkan Med J        ISSN： 2146-3123            Impact factor:   2.021


× No keyword cloud information.
  5 in total

1.  Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.

Authors:  Miklos Pless; Roger Stupp; Hans-Beat Ris; Rolf A Stahel; Walter Weder; Sandra Thierstein; Marie-Aline Gerard; Alexandros Xyrafas; Martin Früh; Richard Cathomas; Alfred Zippelius; Arnaud Roth; Milorad Bijelovic; Adrian Ochsenbein; Urs R Meier; Christoph Mamot; Daniel Rauch; Oliver Gautschi; Daniel C Betticher; René-Olivier Mirimanoff; Solange Peters
Journal:  Lancet       Date:  2015-08-11       Impact factor: 79.321

2.  Another Reason to Omit Induction Radiotherapy: Save It for Last.

Authors:  Çağatay Tezel; Serdar Evman; Talha Doğruyol
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

Review 3.  Neoadjuvant radiotherapy/chemoradiotherapy in locally advanced non-small cell lung cancer.

Authors:  Deniz Yalman
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

4.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

5.  Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.

Authors:  K S Albain; V W Rusch; J J Crowley; T W Rice; A T Turrisi; J K Weick; V A Lonchyna; C A Presant; R J McKenna; D R Gandara
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544
  5 in total
  1 in total

1.  Another Reason to Omit Induction Radiotherapy: Save It for Last.

Authors:  Çağatay Tezel; Serdar Evman; Talha Doğruyol
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.